Publications by authors named "Giulia Marcantognini"

Claim this Profile
T
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis.
Edoardo Lenci, Giulia Marcantognini, Valeria Cognigni, Alessio Lupi, Silvia Rinaldi

Explor Target Antitumor Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions.
Rossana Berardi, Gaia Goteri, Silvia Pagliaretta, Vittorio Paolucci, Francesca Morgese, Giulia Marcantognini

J Thorac Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach.
Rossana Berardi, Gaia Goteri, Alessandro Brunelli, Silvia Pagliaretta, Vittorio Paolucci, Giulia Marcantognini

Expert Opin Ther Targets· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
Luca Cantini, Filippo Merloni, Silvia Rinaldi, Edoardo Lenci, Giulia Marcantognini

Crit Rev Oncol Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic.
Zelmira Ballatore, Lucia Bastianelli, Filippo Merloni, Nicoletta Ranallo, Luca Cantini, Giulia Marcantognini

JCO Glob Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review.
Mariagrazia De Lisa, Zelmira Ballatore, Giulia Marcantognini, Chiara Pierantoni, Stefania Antognoli

Oncol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study.
Rossana Berardi, Federico Mocchegiani, Silvia Rinaldi, Ilaria Fiordoliva, Francesca Rovinelli, Giulia Marcantognini

Oncol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.
Alberto Bongiovanni, Federica Recine, Monica Celli, Giulia Marcantognini, Flavia Foca

Medicine (Baltimore)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.
Manlio Monti, Danila Diano, Francesco Allegrini, Angelo Delmonte, Valentina Fausti, Giulia Marcantognini

BMC Infect Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
Rossana Berardi, Alessandro Brunelli, Silvia Pagliaretta, Vittorio Paolucci, Alessandro Conti, Giulia Marcantognini

Oncotarget· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis